About
PreciseDx develops an AI-powered diagnostic platform, PreciseBreast®, that analyzes breast cancer tissue samples to provide rapid, objective risk stratification of disease recurrence, improving tumor grading accuracy and reducing reliance on costly gene expression testing.
Explore PreciseDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.